Opendata, web and dolomites

AllergyExplorer SIGNED

Automation of novel multi-parameter allergy test that is cost-efficient and delivers instantly correct results

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 AllergyExplorer project word cloud

Explore the words cloud of the AllergyExplorer project. It provides you a very rough idea of what is the project "AllergyExplorer" about.

declared    vitro    manual    bn    off    instead    instrumentation    delivering    quality    estimate    health    annual    clearer    diagnosis    supplier    automate    validated    complete    recommendations    140    individual    valuable    population    global    tested    allergies    treatment    lab    allergens    practitioners    time    customer    registered    eliminate    diagnosed    rate    customers    solution    2016    single    return    diagnostics    prior    substantiates    anamnesis    public    adequately    immunotherapy    patients    asthma    union    few    approx    labs    market    risk    forcing    life    century    avoidance    half    globally    usd    allergen    double    quarter    clinical    100    facto    21st    provides    amounted    points    trade    independent    enhanced    device    close    optimal    insufficiently    monopoly    digit    technically    allergy    select    spent    multiply    selling    fast    profile    immunological    experts    expand    pressure    automated    therapeutic    allergic    decision    million    medical    saved    routine    jobs    almost    molecular    revenues    least    de    700    segments   

Project "AllergyExplorer" data sheet

The following table provides information about the project.

Coordinator
MACROARRAY DIAGNOSTICS GMBH 

Organization address
address: GUTHEIL SCHODER GASSE 17 TECHPARK VIENNA STIEGE 3
city: WIEN
postcode: 1230
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Austria [AT]
 Total cost 3˙536˙250 €
 EC max contribution 2˙475˙375 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2018
 Duration (year-month-day) from 2018-06-01   to  2020-05-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MACROARRAY DIAGNOSTICS GMBH AT (WIEN) coordinator 2˙475˙375.00

Map

 Project objective

Allergies and asthma affect at least a quarter of the population and the WHO has declared allergy a major health problem of the 21st century. Currently, medical practitioners must pre-select very few allergens for in-vitro testing, based on prior anamnesis, under time and cost pressure. Independent experts estimate that almost half of the patients are diagnosed insufficiently. The consequences for the patients are not optimal treatment and reduced quality of life. For the public health systems more than 140 Bn Euro are spent each year which could be saved if all allergic patients were treated adequately. We have developed a multi-parameter allergy test covering close to 100% of the globally relevant allergens in a single lab test. Instead of forcing medical practitioners to pre-select very few allergens for in-vitro, our solution substantiates any therapeutic decision by offering a complete immunological profile for every tested individual. We expand testing to the molecular level which provides valuable decision points such as enhanced risk assessment, improving the success of allergen immunotherapy or clearer recommendations for avoidance. We eliminate the trade-off between cost and quality of allergy diagnosis. Our allergy test is technically validated and registered as an in-vitro diagnostics device in Europe. We are already selling and delivering the non-automated manual test systems to customers all over Europe. In this project, we will fully automate the test instrumentation so we can target the customer segments of highly automated clinical routine labs. This will multiply our selling potential and expand our customer reach. The global market of in-vitro diagnosis of allergy is growing fast at almost double-digit rate globally, and amounted to approx. 700 million USD annual revenues in 2016. There is a de-facto monopoly of a single US supplier and this project will return jobs and revenues to the European Union.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ALLERGYEXPLORER" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ALLERGYEXPLORER" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Presque (2019)

Smart Nursing Bra

Read More  

HAC (2019)

ADVANCED TREATMENT OF CONTAMINATED SOIL

Read More  

HUD (2018)

COMMERCIALIZING THE FIRST HEAD-UP-DISPLAY FOR OFF-HIGHWAY VEHICLES

Read More